DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

31.70 0.12 (0.38%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NBIX $31.70 0.38%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $31.54
Previous Close $31.58
Daily Range $31.07 - $31.89
52-Week Range $12.17 - $32.67
Market Cap $2.4B
P/E Ratio -43.86
Dividend (Yield) $0.00 (0.0%)
Volume 454,764
Average Daily Volume 1,431,449
Current FY EPS -$0.80

Sector

Healthcare

Industry

Drugs

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary Rss Feed

Cancel JPMorgan! Plenty of Pre-Conference Data and Deals to Digest

The week before JPMorgan Healthcare conference brought a plethora of deals and data.

Stocks Hitting 52-Week Highs

Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

Neurocrine Biosciences Starts A Data-Rich Year On The Right Foot

Why Neurocrine Biosciences, Inc. Shares Took Off Today

Is this meaningful? Or just another movement?

Mid-Morning Market Update: Markets Jump; Family Dollar Profit Misses Estimates

Mid-Morning Market Update: Markets Jump; Family Dollar Profit Misses Estimates

Benzinga's Volume Movers

6 Serious Biotech and Health Care Movers

Our 3 Best Performing Stocks Of 2014

See More NBIX News...

NBIX's Top Competitors

NBIX $31.70 (0.38%)
Current stock: NBIX
AMGN $159.81 (0.15%)
Current stock: AMGN
GILD $105.54 (0.38%)
Current stock: GILD
BIIB $357.63 (1.13%)
Current stock: BIIB